Search Results

There are 661 results for: content related to: Concordance between sustained virologic response week 12 (SVR12) and SVR24 in genotype 1 hepatitis C virus patients receiving interferon-free treatment in the SOUND-C2 study

  1. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  2. You have free access to this content
    Poster Session II (Abstracts 730 – 1194)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 361–601,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28798

  3. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  4. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533

  5. Perspectives on HCV: Current Therapeutic Regimens and Drug–Drug Interactions

    Clinical Pharmacology in Drug Development

    Volume 6, Issue 2, March/April 2017, Pages: 147–163, Justin Chan and Raymond T. Chung

    Version of Record online : 6 MAR 2017, DOI: 10.1002/cpdd.338

  6. You have free access to this content
    Poster Session 1: Stem Cell Biology; Therapeutics: New Agents (not approved, phase 2–3)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 544A–574A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28216

  7. You have free access to this content
    Hepatitis-Viral

    Journal of Gastroenterology and Hepatology

    Volume 32, Issue S2, August 2017, Pages: 65–86,

    Version of Record online : 17 AUG 2017, DOI: 10.1111/jgh.13892

  8. You have free access to this content
    Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1004–1012, Bashar A. Aqel, Surakit Pungpapong, Michael Leise, K. Tuesday Werner, Amy E. Chervenak, Kymberly D. Watt, Jennifer L. Murphy, Kristen Ryland, Andrew P. Keaveny, Ryan McLemore and Hugo E. Vargas

    Version of Record online : 7 AUG 2015, DOI: 10.1002/hep.27937

  9. You have full text access to this OnlineOpen article
    All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study

    Hepatology

    Volume 61, Issue 4, April 2015, Pages: 1127–1135, David R. Nelson, James N. Cooper, Jacob P. Lalezari, Eric Lawitz, Paul J. Pockros, Norman Gitlin, Bradley F. Freilich, Ziad H. Younes, William Harlan, Reem Ghalib, Godson Oguchi, Paul J. Thuluvath, Grisell Ortiz-Lasanta, Mordechai Rabinovitz, David Bernstein, Michael Bennett, Trevor Hawkins, Natarajan Ravendhran, Aasim M. Sheikh, Peter Varunok, Kris V. Kowdley, Delphine Hennicken, Fiona McPhee, Khurram Rana, Eric A. Hughes and on behalf of the ALLY-3 Study Team

    Version of Record online : 10 MAR 2015, DOI: 10.1002/hep.27726

  10. You have free access to this content
    HCV Therapeutics: New Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 730A–760A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26858

  11. You have free access to this content
    Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 12, June 2016, Pages: 1276–1292, A. Majumdar, M. T. Kitson and S. K. Roberts

    Version of Record online : 18 APR 2016, DOI: 10.1111/apt.13633

  12. You have free access to this content
    Hepatitis C virus genotype 4: Genotype 1's little brother

    Journal of Viral Hepatitis

    Volume 24, Issue 1, January 2017, Pages: 4–12, J. Llaneras, M. Riveiro-Barciela, M. Buti and R. Esteban

    Version of Record online : 1 DEC 2016, DOI: 10.1111/jvh.12620

  13. You have full text access to this OnlineOpen article
    Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study

    Hepatology

    Volume 64, Issue 2, August 2016, Pages: 370–380, Paul Kwo, Norman Gitlin, Ronald Nahass, David Bernstein, Kyle Etzkorn, Sergio Rojter, Eugene Schiff, Mitchell Davis, Peter Ruane, Ziad Younes, Ronald Kalmeijer, Rekha Sinha, Monika Peeters, Oliver Lenz, Bart Fevery, Guy De La Rosa, Jane Scott and James Witek

    Version of Record online : 22 MAR 2016, DOI: 10.1002/hep.28467

  14. On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3–infected patients treated with daclatasvir and sofosbuvir

    Liver International

    Volume 36, Issue 11, November 2016, Pages: 1611–1618, Kris V. Kowdley, David R. Nelson, Jacob P. Lalezari, Terry Box, Norman Gitlin, Gary Poleynard, Mordechai Rabinovitz, Natarajan Ravendhran, Aasim M. Sheikh, Asma Siddique, Rafia Bhore, Stephanie Noviello and Khurram Rana

    Version of Record online : 16 JUN 2016, DOI: 10.1111/liv.13165

  15. You have full text access to this OnlineOpen article
    Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2)

    Hepatology

    Volume 64, Issue 2, August 2016, Pages: 360–369, Eric Lawitz, Gary Matusow, Edwin DeJesus, Eric M. Yoshida, Franco Felizarta, Reem Ghalib, Eliot Godofsky, Robert W. Herring, Gary Poleynard, Aasim Sheikh, Hillel Tobias, Marcelo Kugelmas, Ronald Kalmeijer, Monika Peeters, Oliver Lenz, Bart Fevery, Guy De La Rosa, Jane Scott, Rekha Sinha and James Witek

    Version of Record online : 19 FEB 2016, DOI: 10.1002/hep.28422

  16. Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration

    Journal of Gastroenterology and Hepatology

    Volume 32, Issue 6, June 2017, Pages: 1136–1142, D Steven Fox, Justin J McGinnis, Ivy Q Tonnu-Mihara and Jeffrey S McCombs

    Version of Record online : 30 MAY 2017, DOI: 10.1111/jgh.13652

  17. You have free access to this content
    Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis C virus

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 12, December 2014, Pages: 1653–1666, Bryant B. Summers, Joshua W. F. Beavers and Olga M. Klibanov

    Version of Record online : 31 AUG 2014, DOI: 10.1111/jphp.12294

  18. You have full text access to this OnlineOpen article
    Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus

    Hepatology

    Volume 61, Issue 1, January 2015, Pages: 41–45, Eric M. Yoshida, Mark S. Sulkowski, Edward J. Gane, Robert W. Herring Jr., Vlad Ratziu, Xiao Ding, Jing Wang, Shu-Min Chuang, Julie Ma, John McNally, Luisa M. Stamm, Diana M. Brainard, William T. Symonds, John G. McHutchison, Kimberly L. Beavers, Ira M. Jacobson, K. Rajender Reddy and Eric Lawitz

    Version of Record online : 24 NOV 2014, DOI: 10.1002/hep.27366

  19. You have full text access to this OnlineOpen article
    Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence

    Hepatology

    Volume 63, Issue 5, May 2016, Pages: 1493–1505, Fred Poordad, Eugene R. Schiff, John M. Vierling, Charles Landis, Robert J. Fontana, Rong Yang, Fiona McPhee, Eric A. Hughes, Stephanie Noviello and Eugene S. Swenson

    Version of Record online : 7 MAR 2016, DOI: 10.1002/hep.28446

  20. You have free access to this content
    Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 5, March 2014, Pages: 478–487, R. S. Koff

    Version of Record online : 6 JAN 2014, DOI: 10.1111/apt.12601

    Corrected by:

    Corrigenda: Corrigenda

    Vol. 39, Issue 8, 904, Version of Record online: 17 MAR 2014